News

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...
The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...
Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...
Columnist Dagmar Munn hopes everyone will send out a mayday call during this ALS Awareness Month, to spread the urgent needs ...
The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.
Two things that are constantly required in life with ALS are love and patience, writes columnist. A little laughter also helps.
Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) for SPG302, its oral treatment for amyotrophic lateral sclerosis (ALS).
Prilenia Therapeutics has entered a collaboration and license agreement with Ferrer to codevelop and commercialize pridopidine, its therapy candidate for neurodegenerative diseases like amyotrophic ...